IL77666A - Diagnostic method for diseases having an arthritic component by determining the deficiency of galactose in igg component of the patient's serum,plasma or synovial fluid - Google Patents

Diagnostic method for diseases having an arthritic component by determining the deficiency of galactose in igg component of the patient's serum,plasma or synovial fluid

Info

Publication number
IL77666A
IL77666A IL77666A IL7766686A IL77666A IL 77666 A IL77666 A IL 77666A IL 77666 A IL77666 A IL 77666A IL 7766686 A IL7766686 A IL 7766686A IL 77666 A IL77666 A IL 77666A
Authority
IL
Israel
Prior art keywords
component
galactose
deficiency
diseases
plasma
Prior art date
Application number
IL77666A
Other languages
English (en)
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of IL77666A publication Critical patent/IL77666A/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/827Lectins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Control Of El Displays (AREA)
IL77666A 1985-01-22 1986-01-21 Diagnostic method for diseases having an arthritic component by determining the deficiency of galactose in igg component of the patient's serum,plasma or synovial fluid IL77666A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/693,075 US4659659A (en) 1985-01-22 1985-01-22 Diagnostic method for diseases having an arthritic component

Publications (1)

Publication Number Publication Date
IL77666A true IL77666A (en) 1990-12-23

Family

ID=24783210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77666A IL77666A (en) 1985-01-22 1986-01-21 Diagnostic method for diseases having an arthritic component by determining the deficiency of galactose in igg component of the patient's serum,plasma or synovial fluid

Country Status (14)

Country Link
US (1) US4659659A (da)
EP (1) EP0189388B1 (da)
JP (1) JP2515289B2 (da)
AT (1) ATE78518T1 (da)
AU (1) AU586662B2 (da)
CA (1) CA1272670A (da)
DE (1) DE3686061T2 (da)
DK (1) DK164417C (da)
FI (1) FI88341C (da)
GR (1) GR860167B (da)
IE (1) IE58727B1 (da)
IL (1) IL77666A (da)
NO (1) NO166302C (da)
ZA (1) ZA86442B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component
GB8618443D0 (en) * 1986-07-29 1986-09-03 Univ London Monoclonal antibodies
GB8714270D0 (en) * 1987-06-18 1987-07-22 Williams G R Analysis of carbohydrates
US4791067A (en) * 1987-06-25 1988-12-13 Fisher Scientific Co. Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5100778A (en) * 1989-10-03 1992-03-31 Monsanto Company Oligosaccharide sequencing
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
JP3537535B2 (ja) * 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases
IL129835A (en) * 1999-05-06 2008-03-20 Ofer Markman Polysaccharide sequencing and structure determination
US20040132131A1 (en) * 2001-11-05 2004-07-08 Ofer Markman Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
PT1583968E (pt) * 2003-01-14 2015-09-14 Vzw Vib Um marcador sérico para medição da fibrose hepática
AU2004222345A1 (en) * 2003-03-14 2004-09-30 Ppd Biomarker Discovery Sciences, Llc Biological markers for diagnosing rheumatoid arthritis
WO2005015200A1 (ja) * 2003-08-11 2005-02-17 Shionogi Co., Ltd. 血清を用いた簡易疾患診断およびテーラーメイド治療
EP1709443A2 (en) * 2003-12-18 2006-10-11 Procognia, Ltd. Method for analyzing a glycomolecule
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US8039208B2 (en) * 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US7892752B2 (en) * 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
EP1919286A4 (en) * 2005-06-10 2013-07-10 Mannatech Inc SACCHARIDBIOMARKER QUICK TEST
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
DK2068918T4 (da) 2006-09-26 2024-09-02 Access To Advanced Health Inst Vaccinesammensætning omfattende syntetisk adjuvant
US20100266558A1 (en) * 2007-12-18 2010-10-21 Dov Zipori Method and assay for glycosylation pattern detection related to cell state of stem cells
EP3124491B1 (en) * 2009-06-05 2019-10-30 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions as well as pharmaceutical compositions containing them
JP6054942B2 (ja) 2011-04-08 2016-12-27 イミューン デザイン コーポレイション 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
CN107540730B (zh) 2012-05-16 2021-07-16 免疫设计公司 用于hsv-2的疫苗
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
KR102411781B1 (ko) 2013-12-31 2022-06-22 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) 단일 바이알 백신 제형
WO2017210364A1 (en) 2016-06-01 2017-12-07 Infectious Disease Research Institute Nanoalum particles containing a sizing agent
AU2020283768A1 (en) 2019-05-25 2021-12-23 Access To Advanced Health Institute Composition and method for spray drying an adjuvant vaccine emulsion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088875A (en) * 1959-10-27 1963-05-07 Hyland Lab Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4213764A (en) * 1978-08-09 1980-07-22 Akzona Incorporated Method for determining immunochemical substances
US4282002A (en) * 1979-09-06 1981-08-04 Akzona Incorporated Sensitized sheep stroma immunoassay for rheumatoid factor
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4457865A (en) * 1982-03-08 1984-07-03 Research Corporation Sialic acid specific slug lectin
US4420461A (en) * 1982-05-26 1983-12-13 Ortho Diagnostic Systems Inc. Agglutination-inhibition test kit for detecting immune complexes
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component

Also Published As

Publication number Publication date
DK164417B (da) 1992-06-22
ZA86442B (en) 1986-10-29
AU586662B2 (en) 1989-07-20
NO166302C (no) 1991-06-26
DE3686061D1 (de) 1992-08-27
DK29086D0 (da) 1986-01-21
FI860284A (fi) 1986-07-23
CA1272670C (en) 1990-08-14
FI860284A0 (fi) 1986-01-21
JPS61170657A (ja) 1986-08-01
DE3686061T2 (de) 1993-03-11
FI88341C (fi) 1993-04-26
EP0189388A2 (en) 1986-07-30
EP0189388A3 (en) 1988-11-30
IE58727B1 (en) 1993-11-03
EP0189388B1 (en) 1992-07-22
IE860176L (en) 1986-07-22
GR860167B (en) 1986-05-22
AU5253886A (en) 1986-07-31
ATE78518T1 (de) 1992-08-15
DK29086A (da) 1986-07-23
FI88341B (fi) 1993-01-15
JP2515289B2 (ja) 1996-07-10
CA1272670A (en) 1990-08-14
DK164417C (da) 1992-11-16
NO860191L (no) 1986-07-23
US4659659A (en) 1987-04-21
NO166302B (no) 1991-03-18

Similar Documents

Publication Publication Date Title
IL77666A (en) Diagnostic method for diseases having an arthritic component by determining the deficiency of galactose in igg component of the patient's serum,plasma or synovial fluid
ES2014540A6 (es) Metodo para la determinacion de fragmentos peptidicos con un entrecruzamiento 3-hidroxipiridinio en un fluido corporal.
OA08412A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinomas.
EP0644412A3 (de) Verfahren zur Analyse klinisch relevanter Flüssigkeiten und Suspensionen.
GB2205643B (en) Type iii collagen degradation assay
GR851540B (da)
EP0419502A4 (en) Method of detecting bacteria in urine
AU7626787A (en) Method of detecting or estimating biological material
GB9506050D0 (en) Assaying collagen fragments in body fluids
EP0585960A3 (en) Diagnostic method for autoimmune diseases
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
DE3568589D1 (en) Diagnostic assay method for the detection of oral pathogenic bacteria mixtures
DE3362255D1 (en) Home diagnostic aid and method for determining the presence of occult blood
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
EP0217768A3 (en) Method and compositions for heparin assays
EP0398292A3 (en) Diagnostic composition for rheumatoid arthritis
GR900100011A (en) New diagnostic method
EP0788595A4 (en) METHOD FOR TESTING IMMUNOCOMPETENCY
RU94039686A (ru) Способ определения активности клеточного иммунитета
SG45274A1 (en) Method and apparatus for measuring the degree of reaction between a foreign entity and a subject's blood cells
UA23350A (uk) Спосіб діагhостики хвороб, що передаються статевим шляхом (сифіліс, сhід, гепатит в та іhші) та автоматизоваhий пристрій для його викоhаhhя
UA10243A (uk) Спосіб диференційної діагностики вірусних гепатитів а і в у дітей

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed
EXP Patent expired